Reflections on the Innovative Medicines Initiative

被引：0
|
作者：
Michel Goldman
机构：
[1] Michel Goldman is Executive Director of the Innovative Medicines Initiative,
[2] B-1060 Brussels,undefined
[3] Belgium.,undefined
来源：
Nature Reviews Drug Discovery | 2011年 / 10卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The pharmaceutical industry is developing new collaborative models for drug development. This article discusses the experience so far of the Innovative Medicines Initiative, which is currently the largest public–private partnership that is dedicated to pharmaceutical innovation, highlighting lessons learned for the success of precompetitive consortia.
引用
收藏
页码：321 / 322
页数：1
相关论文
共 50 条
  • [1] Reflections on the Innovative Medicines Initiative
    Goldman, Michel
    NATURE REVIEWS DRUG DISCOVERY, 2011, 10 (05) : 321 - 322
  • [2] Erratum: Reflections on the Innovative Medicines Initiative
    Michel Goldman
    Nature Reviews Drug Discovery, 2011, 10 : 471 - 471
  • [3] Will the Innovative Medicines Initiative really deliver innovative medicines?
    Wilkinson, Emma
    MOLECULAR ONCOLOGY, 2008, 2 (03) : 203 - 205
  • [4] Reflections on the Innovative Medicines Initiative (vol 10, pg 321, 2011)
    Goldman, Michel
    NATURE REVIEWS DRUG DISCOVERY, 2011, 10 (06) : 475 - 475
  • [5] Innovative Medicines Initiative and antibiotic resistance
    Kostyanev, Tarnishiv
    Bonten, Marc J. M.
    O'Brien, Seamus
    Goossens, Herman
    LANCET INFECTIOUS DISEASES, 2015, 15 (12): : 1373 - 1375
  • [6] INNOVATIVE MEDICINES INITIATIVE: THE SPRINTT PROJECT
    Marzetti, E.
    Calvani, R.
    Landi, F.
    Hoogendijk, E.
    Fougere, B.
    Vellas, B.
    Pahor, M.
    Bernabei, R.
    Cesari, M.
    JOURNAL OF FRAILTY & AGING, 2015, 4 (04): : 207 - 208
  • [7] Benchmarking the scientific output of the Innovative Medicines Initiative
    Gunn, Magda
    Lim, Mark
    Cross, Didi
    Goldman, Michel
    NATURE BIOTECHNOLOGY, 2015, 33 (08) : 811 - 812
  • [8] The Innovative Medicines Initiative: an engine for regulatory science
    Michel Goldman
    Nathalie Seigneuret
    Hans-Georg Eichler
    Nature Reviews Drug Discovery, 2015, 14 : 1 - 2
  • [9] Benchmarking the scientific output of the Innovative Medicines Initiative
    Magda Gunn
    Mark Lim
    Didi Cross
    Michel Goldman
    Nature Biotechnology, 2015, 33 : 811 - 812
  • [10] Overviewof the innovative medicines initiative NeuoDerisk project
    Langer, T.
    TOXICOLOGY LETTERS, 2022, 368 : S81 - S81
12345